Novel contributions on luminescent apatite-based colloids intended for medical imaging by Al-Kattan, Ahmed et al.
Any correspondence concerning this service should be sent to the repository administrator: 
staff-oatao@inp-toulouse.fr 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identification  number: DOI : 10.1177/0885328212473510 
Official URL: http://dx.doi.org/10.1177/0885328212473510 
 
  
 
This is an author-deposited version published in: http://oatao.univ-toulouse.fr/  
Eprints ID: 12048 
To cite this version:  
Al-Kattan, Ahmed and Santran, Véronique and Dufour, Pascal and Dexpert-
Ghys, Jeannette and Drouet, Christophe Novel contributions on luminescent 
apatite-based colloids intended for medical imaging. (2014) Journal of 
Biomaterials Applications, vol. 28 (n° 5). pp. 697-707. ISSN 0885-3282 
Open Archive Toulouse Archive Ouverte (OATAO)  
OATAO is an open access repository that collects the work of Toulouse researchers and 
makes it freely available over the web where possible.  
 
Novel contributions on luminescent
apatite-based colloids intended for
medical imaging
Ahmed Al-Kattan1, Veronique Santran2, Pascal Dufour1,
Jeannette Dexpert-Ghys3 and Christophe Drouet1
Abstract
The setup of colloidal hybrid nanosystems based on biomimetic calcium phosphate apatites doped with europium ions
has recently raised great interest in the pharmacological community, especially due to their bio-inspired character. This is
especially relevant in relation with medical imaging for cancer diagnosis. Questions however remain in relation to a
number of applicability aspects, some of which have been examined in this contribution. In a first part of this work, we
explored further the luminescence properties of such colloidal nanoparticles. We pointed out, upon excitation of
europium, the existence of some non-radiative de-excitation via the vibration of O-H oscillators located at the vicinity
of the Eu3þ luminescent centers. The replacement of Eu3þ by Tb3þ ions, less prone to non-radiative de-excitation, was
then tested in a preliminary way and can be seen as a promising alternative. In a second part of this work, we inspected
the possibility to store these colloids in a dry state while retaining a re-suspension ability preserving the nanometer size
of the initial nanoparticles, and we propose a functional protocol involving the addition of glucose prior to freeze-drying.
We finally showed for the first time, based on titrations of intracellular Ca2þ and Eu3þ ions, that folic acid-functionalized
biomimetic apatite nanoparticles were able to target cancer cells that overexpress folate receptors on their membrane,
which we point out here in the case of T-47-D breast carcinoma cells, as opposed to ZR-75-1 cells that do not express
folate receptors. This contribution thus opens new exciting perspectives in the field of targeted cancer diagnosis, thus
confirming the promise of biomimetic apatites-based colloidal formulations.
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Bionanotechnology, materials-cells interactions, colloids, hybrid materials, luminescence, cancer, biomimetic apatites,
hydroxyapatite
Introduction
Today, the use of engineered biotechnological nanosys-
tems such as gold nanoparticles,1 quantum dots,2 poly-
mer-based nanospheres,3 liposomes,4 and more recently
biomimetic apatite-based hybrid nanoparticles,5–7
among other systems, is considered a promising
approach in view of tailored diagnosis and/or treatment
applications, especially in link with cancer pathologies.
The fate of such nanosystems once in vivo as well as
their biocompatibility is however of continual concern,
whether these nanosystems are envisioned for diagnosis
aspects or for therapeutic applications (localized drug
delivery). Also, these systems become all the more
appealing that they exhibit a targeting activity towards
specific types of cells or tissues. Such nanosystems able
to target specifically cancer cells need to comply with
several characteristics including biocompatibility, the
possibility to control their size in the nanometer scale
(typically under 100 nm), and the possibility to functio-
nalize their surface with a cell-targeting agent (e.g. pep-
tides, vitamins, antibodies. . .).
Nanosystems inspired from nature itself are
bound to be especially well-suited to nanomedicine
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applications taking into account their intrinsic biocom-
patibility, which explains the ever-growing load of
work being investigated worldwide in this domain.
Among bio-inspired nanosystems, those based on cal-
cium phosphate biomimetic apatites (similar to those
already found in the body in bone mineral) appear as
promising candidates due to the ability to tailor and
exploit their exceptional surface properties enabling in
particular various types of surface functionaliza-
tion.8–12 Previous works showed the possibility to syn-
thesize, by a soft chemistry route starting from easily
handled ionic salts, some luminescent colloidal nanop-
robes based on europium-doped biomimetic apatite
nanoparticles, dedicated to medical imaging, and
demonstrated several benefits: (1) these systems are
based on bio-inspired and exhibit a structure that
allows several ionic substitutions (e.g. Ca2þ/Eu3þ)7,13
as well as a functionalizable surface; (2) it is possible
to obtain colloid-like suspensions, for instance upon
surface grafting of a phospholipid moiety (2-ami-
noethylphosphoric acid, AEP)14 that is also biocompat-
ible as already present on the surface of human cells; (3)
the mean nanoparticle size in suspension can be con-
trolled down to about 30–40 nm by the amount of
grafted AEP on the surface of apatite particles;7 these
systems exhibit a long luminescence lifetime (close to
1ms)7 allowing long analyses of biological tissues, pos-
sibly through time-resolved luminescence techniques.
Also, a recent study showed the possibility to functio-
nalize such apatite-based hybrid nanoparticles by a tar-
geting agent: folic acid (B9 vitamin), a tumor cell
marker, thus opening potential perspectives for cancer
targeting.5 Preliminary biological tests were also
initiated in order to better understand the nanoparti-
cles-immunological system (typically human mono-
cytes) interaction, and no pro-inflammatory potential
was detected for such colloidal nanoparticles at the
concentrations used for detection. In addition, cytotox-
icity measurements pointed out their low cytotoxicity,
thus allowing their potential use in biomedical applica-
tions.5 Finally, in vitro experiments revealed that such
nanoparticles were internalizable (possibly via endo-
cytosis) by ZR-75-1 breast carcinoma cells.5
Although the above-mentioned results stress the
promise of such biomimetic apatite-based nanosystems
in nanomedicine, some aspects still remain to be
explored further. Of particular relevance is a further
exploration of their luminescence properties, in view
of a possible optimization. Another point of interest
would be related to the possibility to store such suspen-
sions for extended periods of time without alteration
(e.g. particle size evolution with time). Finally, the
cell-targeting ability of such nanoparticles still has to
be investigated so as to examine the possibility to target
specifically some types of cancer cells. In this paper,
we explore these three aspects and discuss our results
in link with possible upcoming applications in nanome-
dicine and more specifically concerning the field of
nano-oncology.
Materials and methods
Preparation of apatite colloidal suspensions
The synthesis protocol used in this work for preparing
apatite-based colloids is described in detail in our pre-
cedent work.7 Briefly, three starting aqueous solutions
are prepared: solution (A) consisting in a mixture of
calcium and europium (or terbium as indicated in the
text) nitrates. The Ln/(Ca þ Ln) mole ratio, where Ln
stands for the lanthanide ions used (Eu3þ or Tb3þ),
was set here to 1.5mol%. The total CaþLn amount
in solution (A) was 4.87mmol dissolved in 6.25ml of
deionized water. The second solution, named (B), was
obtained by dissolving 4.87mmol of AEP in 6.25ml of
deionized water. Finally, solution (C) was composed
of 1.62mmol of ammonium hydroge´nophosphate dis-
solved in 12.5ml of deionized water. Solution (A) was
added under stirring to solution (B) and the pH of the
mixture was adjusted to 9.5. The pH of solution (C)
was also adjusted to 9.5 and added to the previous
mixture. The suspension was then introduced in an
oven preset at 100C, for 16 h, for an ageing step.
The colloidal suspension obtained was then purified
by dialysis process as detailed elsewhere.15 The final
pH of the suspension was then reduced to physio-
logical value (pH 7.4) by addition of ca. 3ml of
sodium hexametaphosphate (HMP) at a concentration
of 0.08M.
For studying re-dispersion aspects, an addition of
glucose (as mentioned in the text) has been made in
the colloidal suspensions (purified by dialysis and trea-
ted with HMP, as mentioned above) prior to freeze-
drying. Three concentrations of glucose were tested,
3.7, 11.1, and 18.5mg/ml (corresponding respectively
to the introduction of 50, 150, and 250mg of glucose
in 13.5ml of colloid composed of 12ml of colloid and
1ml of HMP solution at 0.08M)); and the re-suspen-
sion was performed after freeze-drying by addition of
13.5ml of deionized water and sonification during
10 sec.
Association with folic acid
When mentioned in the text, folic acid (denoted ‘‘FA’’)
was added in the reacting medium precisely in the same
time of the preparation of solution (A). The FA con-
centration used was typically 0.45mM. The rest of the
synthesis remained unchanged.
Physico-chemical characterizations
The crystallographic structure of the nanoparticles was
checked, after freeze-drying, by X-ray diffraction
(XRD) using a CPS 120 INEL diffractometer with
the K
a1 cobalt radiation (¼ 1.78892 A˚). Fourier-trans-
form infrared (FTIR) analyses were performed using a
Nicolet 5700 spectrometer. The wavenumber analysis
window was set to 400–4000 cmÿ1, with a resolution
of 4 cmÿ1. The particle size (hydrodynamic diameter,
Dh) of the colloids was determined by dynamic light
scattering (DLS) with a Nanosizer ZS apparatus from
Malvern Instruments (¼ 630 nm). The dispersion of
the data points is estimated to 0.5%. The same appar-
atus was used for zeta potential measurements, using a
capillary cell, by a combination of electrophoresis and
Laser Doppler velocimetry (allowing the measurement
of the particle velocity in the liquid phase when an elec-
trical field is applied).
The luminescence properties of the colloids doped
with Tb3þ and Eu3þ were investigated using a Horiba
Jobin Yvon Fluorolog 3-11 spectrofluorometer
equipped with a 450 W xenon lamp. Excitation and
emission were measured at room temperature directly
on the colloidal suspensions, after dialysis. Concerning
Eu3þ, excitation spectra were recorded between 350 nm
and 600 nm by monitoring the [Eu3þ] 5D0!
7F2 emis-
sion at em¼ 612 nm (spectral bandwidth¼ 2 nm).
Emission spectra were recorded in the 500–700 nm
range, with spectral bandwidth of 1 nm, under selected
excitation in the [Eu3þ] 7F0!
5L6 of Eu
3þ at
ex¼ 392.8 nm. For Tb
3þ, excitation spectra were rec-
orded between 200 nm and 500 nm by monitoring the
[Tb3þ] 5D4!
7F5 emission at em¼ 540 nm (spectral
bandwidth¼ 2 nm). Emission of Tb3þ in the 410–
700 nm range, with spectral bandwidth of 2 nm, under
selected excitation in the [Tb3þ] 7F6!
5G6 transition at
ex¼ 379 nm. The transient characteristics of the emit-
ting level 5D4 and
5D0, respectively, of Tb
3þ and Eu3þ
were investigated with the phosphorimeter FL-1040,
equipped with a UV xenon flash tube. Emission
decays were analyzed at chosen ex and em on a time
interval up to 8ms. The analysis was made in quadru-
plicate for colloids prepared in H2O and in triplicate for
colloids prepared in D2O, and the results are reported
in terms of mean standard deviation. The time reso-
lution imposed by the apparatus in the experimental
conditions employed is 30 ms.
Evaluation of cell-targeting
This work was performed on both ZR-75-1 and T-47-D
(provider: ATCC) breast carcinoma cells; the latter
being known to over-express folate receptors on their
surface, as opposed to the former.16,17 Cells were
cultivated in IMDM and RPMI, respectively, with
5% fetal calf serum, 1% antibiotics.
The evaluation of cell-targeting ability was based on
measuring the amount of intracellular Ca2þ and Eu3þ
contents found in these cancer cells after a specific con-
tact time with the colloidal nanoparticles, either asso-
ciated to FA or not. The tests were performed by the
ICELLTIS Company (Verniolle, France), based on an
already published protocol18 aimed at determining
intracellular ionic contents: 24 h after seeding, the col-
loid was added to the cells during a contact time set to
24 h. The concentration of nanoparticles in the culture
medium was 1.5mg/ml. After thorough washing with
PBS buffer, the cells were quantified and centrifuged.
The residual pellets could then be dissolved in HCl
(37%) and incubated for 30min at 80C, in view
of quantification of the Eu and Ca contents by ICP-
AES (analyses performed by the MARION
TECHNOLOGIES Company, Verniolle, France).
Taking into account the cell washing/centrifugation
steps in the presence of an aqueous buffer solution
(PBS), the possibilities to have either remaining traces
of europium or calcium ions ‘‘solely’’ adsorbed on the
cells membrane, or to retain particles merely associated
to the cells surface (but not internalized) appear most
unlikely taking into account the solubility character of
the Ca2þ and Eu3þ ions in aqueous media as well as the
high energy engaged in the centrifugation step.
Therefore, the Ca and Eu contents drawn from tests
realized in the presence of the Ca- and Eu-containing
colloidal nanoparticles are expected to be only repre-
sentative of the internalized particles.
As is commonly done in such cell uptake tests, a
negative control was carried out in the absence of nano-
particles, being thus representative of regular cell
status. At no time were the control cells in contact
with any europium-containing compound; and the
unique external calcium ions in contact with control
cells was that contained in the cell media (RPMI: [Ca]
 0.6mM, or IMDM [Ca]  1.49mM). The calcium
content found in control cells relates to the calcium
contained in the intracellular fluid. As expected, control
cells did not show any europium content.
All experiments were performed in triplicate. Data
are presented as mean standard deviation.
Results and discussion
Physico-chemistry / luminescence aspects
The hybrid apatite-based europium-doped suspensions
prepared in this work were fully characterized in a pre-
vious work,7 and only the main physico-chemical data
will be recalled here for the sake of completeness.
Figures 1 and 2, respectively, report an XRD pattern
and an FTIR spectrum, typical of such colloidal nano-
particles (functionalized with AEP), in comparison with
non-colloidal (AEP-free) counterparts. These data
point out in particular the apatitic nature of the par-
ticles (the main XRD diffraction lines corresponding to
hydroxyapatite, space group P63/m (hexagonal), are
added on Figure 1). The presence of AEP molecules
associated with the apatite phase is at the origin of a
decrease in crystallinity state for the apatite phase, as
indicated by Figure 1, which may be related to the
occupation of crystal growth sites by AEP molecules
during the crystallization process. The functionaliza-
tion of the particles by AEP can be directly evidenced
by FTIR analysis (Figure 2), thanks to the presence of
an absorption band at 754 cmÿ1, which is characteristic
of the P–O(C) libration mode in systems such as
Ca(AEP)2 where a close interaction between AEP mol-
ecules (exhibiting one global negative charge at the syn-
thesis pH) and Ca2þ ions is involved, as was discussed
in previous works.6,7 The decreased crystallinity degree
of the apatite phase obtained in the presence of AEP
(colloidal systems) also leads to a lowered resolution of
the FTIR spectrum, as shown in Figure 2 by compari-
son with an AEP-free system. Moreover, the apatite
phase composing the colloidal particles appears less
hydroxylated (decreased amount of apatitic OH- ions)
as witnessed by the decrease in intensity of the related
bands located at 3572 and 631 cmÿ1. This observation
indicates a greater degree of nonstoichiometry for such
colloidal apatites, which may, again, be related to the
occupation of surface sites by AEP molecules, thus par-
tially hindering the regular nucleation and growth
processes.
Zeta potential measurement obtained with these sus-
pensions was systematically found to be positive, close
to þ12mV, and this positive value is in good agreement
with the presence of grafted AEP molecules, exposing
their ammonium –NH3
þ end-groups toward the solu-
tion (while the phosphate end of the AEP molecule
interacts with the Ca2þ ions).6 In contrast, non-colloi-
dal (i.e. AEP-free) apatite leads to zeta potential values
close to –10mV.
Chemical analyses indicated that the (Ca þ Eu)/P
mole ratio of the apatite phase was close to 1.60, with
an AEP/apatite ratio of 0.63. The experimental value of
the Eu/(Ca þ Eu) mole ratio was 2.03mol%.
DLS experiments (Figure 3, curve (a)) run on the as-
prepared suspensions confirmed the nanometer-scale
dimensions of the particles, with a mean particle size
of 35 nm (monomodal size distribution). DLS measure-
ments performed after purification by dialysis (as
detailed elsewhere)15 followed by the addition of
HMP (up to pH stabilization at 7.4) led to a slight
increase of the mean particle size close to 40.0 nm (see
Figure 3, curve (b)). This size scale, significantly lower
than 100 nm, is thus in a convenient range in view of
intracellular applications.
Europium was used in this system due to several
potential advantages: europium salts generally exhibit
a low toxicity19,20 (especially when it is used in very
small amounts as is the case in the present
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Figure 1. Typical XRD pattern for colloidal biomimetic apatite (AEP-functionalized, prepared at 100C, and pH 9.5), and for a non-
colloidal (AEP-free) counterpart with main XRD line indexation. XRD: X-ray diffraction; AEP: 2-aminoethylphosphoric acid.
contribution); it has a luminescence in the visible spec-
trum, with a long luminescence lifetime; and it allows
the study of biological tissues due to its possible exci-
tation in a low-energy domain (in or near the domain of
visible light). Moreover, this element can be introduced
in the apatite structure thus conferring intrinsic lumi-
nescence properties. These various aspects then enable
one to consider europium as a particularly favorable
element for luminescence applications in biology or
medicine.
Typical excitation and emission spectra for the Eu-
doped colloids developed here are reported in Figure 4.
It is worth noting here that Eu-free samples did not
present any luminescence line features as only a diffuse
background due to the calcium phosphate matrix was
noticed (see background on Figure 4). Moreover, this
background emission is only due to short-lived lumi-
nescence events as it disappears under time-resolved
observation conditions.
The excitation and emission lines reported in
Figure 4 are characteristic of the luminescence behavior
of Eu3þ ions.21 In particular, the main luminescence
maxima are localized here in the ranges 583–603,
605–627 and 685–715 nm and can be assigned, respect-
ively, to the [Eu3þ] 5D0!
7F1,
5D0!
7F2 and
5D0!
7F4 transitions. The broad luminescent back-
ground can be assigned to the photoluminescence of
the apatite matrix itself. The luminescence decay
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Figure 2. FTIR spectrum for colloidal biomimetic apatite (AEP-functionalized, prepared at 100C and pH 9.5), and for a non-colloidal
(AEP-free) counterpart. FTIR: Fourier-transform infrared; AEP: 2-aminoethylphosphoric acid.
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Figure 3. Particle size distributions from dynamic light scattering (DLS). Curve (a): as-synthesized colloid, curve (b): colloid after
purification by dialysis and hexametaphosphate (HMP) addition.
curve, under excitation at 393 nm, with emission moni-
tored at 611.5 nm is shown on Figure 5. It could be
fitted by a mono-exponential decay function and the
lifetime value (obs) was found to reach
1.34 0.14ms. Faster events observed in the first
100 ms of decay have not been taken in the fit. This
value is noticeably larger than the luminescence lifetime
of biological tissue auto-fluorescence (of the order of
the nanosecond), thus enabling one to envision the ana-
lysis of biological materials over extended periods of
time and/or the use of time-resolved luminescence
equipment (e.g. in view of cell sorting).
Taking into account the energy gap EEu3þ corres-
ponding to the [Eu3þ] 5D0!
7FJ transitions, around
15,000 cmÿ1, one possible origin of non-radiative de-
excitation could be through the vibration of O-H oscil-
lators (n 3500 cmÿ1) located at the vicinity of the
Eu3þ luminescent centers. Indeed, EEu3þ happens to
be close from the 4th vibrational harmonic of O-H
oscillators. In order to examine these aspects in more
details, an additional synthesis experiment was carried
out by replacing (deionized) H2O by deuterated water
(D2O), which has the advantages of having the same
physico-chemical properties as H2O but for which O-H
vibrators are replaced by O-D, having a noticeably
lower vibration frequency. In these conditions, only
the 5th vibrational harmonic of O-D may interact
with EEu3þ, thus limiting the probability for vibra-
tional de-excitation to occur, as compared to O-H.
The measure of the characteristic luminescence decay
time for this deuterated suspension led to a value
(2.90 0.29ms) significantly greater than for a non-
deuterated suspension as illustrated in Figure 5.
The so-called ‘‘Horrocks formula’’ has been estab-
lished by measuring the 5D0 exponential decay rate con-
stants of complexes prepared in light and heavy
water.22,23 It predicts the number of water molecules
(which may also be seen as a pair of OH groups) per
Eu3þ emitter (in the first coordination shell):
nH2O ¼
nOH
2
 1:05
1
H2O
ÿ
1
D2O
 
ð1Þ
The application of this equation in our case leads to
0.86 OH groups per europium ion. The location of
Eu3þ ions in the apatite structure has been investigated
in the literature and its preference for Ca(II) sites of the
apatite structure was reported.24 Interestingly, these
crystallographic sites are known to surround the so-
called ‘‘apatitic tunnels’’ that contain the OH- ions of
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Figure 5. Luminescence decays for a Eu-doped suspension prepared in deuterated or in non-deuterated water.
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Figure 4. Excitation (em¼ 612 nm) and emission
(ex¼ 392.8 nm) spectra for Eu-doped apatite-AEP colloids
(spectra uncorrected for the spectral response of the apparatus),
and background emission level due to the calcium phosphate
matrix. AEP: 2-aminoethylphosphoric acid.
the apatite structure, as well as possibly some water
molecules. Therefore, the presence of these species,
implying O-H vibrators, may be at the origin of the
partial non-radiative de-excitation of Eu-doped apa-
tite-based colloids.
The luminescence efficiency ‘‘e’’ can be defined by
the relation e¼ obs/rad, where obs is the experimen-
tally observed luminescence decay time (thus implying
both radiative and non-radiative de-excitation) and
where rad is defined by rad¼ 1/Wrad, Wrad being the
total 5D0 radiative rate. This value may be calculated
from the 5D0!
7FJ emission spectrum and has proven
to be very convenient for comparing different kinds of
compounds containing Eu3þ, especially when absorp-
tion data are not easily available (e.g. due to the tur-
bidity of the suspensions, leading to a non-negligible
amount of diffused light). It has been used in the litera-
ture in numerous cases, as shown for instance in review
articles.25,26
The integrated area of a 5D0!
7FJ emission band,
denoted I(5D0!
7FJ), is directly proportional to the
corresponding radiative rate W0–J, to the number of
active ions in the emitting volume, and to a number
of instrumental parameters hard to estimate; but this
last difficulty can be overcome by considering the inten-
sities relatively to the value of I(5D0!
7F1), taken as a
reference: the 5D0!
7F1 emission is indeed purely
magnetic dipolar in nature and its radiative rate does
not depend on the local field imposed by the environ-
ment. It has been calculated, from theory, that
W0–1¼ 14.65 n
3 (value expressed in sÿ1) where n is the
refractive index of the medium.27 Then:
Ið5D0 !
7FJÞ
Ið5D0 ! 7F1Þ
¼
W0ÿJ
W0ÿ1
ð2Þ
The total 5D0 radiative rate Wrad is the sum of the
W0–J contributions over J¼ 0ÿ 4 (it is, reasonably,
assumed that 5D0!
7F5,6 have negligible intensities).
The emission spectra were corrected for the instrumen-
tal response versus wavelength and the emission back-
ground was subtracted.
This protocol has been applied here taking n¼ 1.33
as the refractive index (that of water), and gives
Wrad¼ 162 s
ÿ1 (rad¼ 6.17ms). The estimated efficiency
for the Eu3þ-doped apatite colloid tested is therefore of
22%. Of course the numerical values of rad and there-
fore that of e greatly depend upon the value chosen
for n. Taking into account the rather low concentration
in nanoparticles in the colloids tested in this study, the
approximation of the value n¼ 1.33 seems reasonable.
In their study on polyphosphate colloidal systems,28
Dias Filho et al. also considered that the medium was
essentially water (n¼ 1.33) and they calculated the max-
imum efficiency of 22% when the europium ions are
well encapsulated by polyphosphate chains. As noticed
in that paper, the 5D0 efficiency of about 20% is quite
high in water solvent.
In the case of apatite colloids, the main non-radia-
tive de-excitation pathway is probably via coupling
with OH-containing species located in the apatitic tun-
nels (mostly in the form of OH- ions) and this number
of hydroxide ions will probably not be easy to lower if
one intends to keep the synthesis at moderate tempera-
ture. Therefore, it was interesting to check here, in a
preliminary approach, the possibility to substitute euro-
pium by another rare earth element less prone to O-H
vibrational de-excitation. This is especially the case for
terbium ions, Tb3þ, which also have a luminescence
signature in visible light, but in the green domain.
The possibility to incorporate Tb3þ ions in apatitic lat-
tices has already been verified in the literature,29 but in
the case of other types of formulations (e.g. involving
DNA), and it thus appeared interesting at this stage to
widen the perspectives of research of the AEP-stabilized
biomimetic apatite colloids prepared here from easily
handled ionic salts.
Therefore, colloidal suspensions doped with Tb3þ
ions were prepared, following the same protocol as
for Eu3þ, and their physico-chemical and luminescence
properties were checked.
The substitution of Eu by Tb was found to lead to
no major modification in the general characteristics of
the apatite phase. Luminescence features were found
(Figure 6) to be characteristic of the excitation and
emission of trivalent terbium ions. As was noticed
above in the case of europium, Tb-free samples did
not exhibit any luminescence line features as only the
calcium phosphate diffuse background was detected
(see background level on Figure 6).
The maximum excitation of Tb3þ was founded at
379 nm, thus close to the visible light domain. The
emission spectrum (recorded under excitation at
379 nm) showed peaks resulting from the 4f-4f transi-
tion of the Tb3þ ions: [Tb3þ] 5D4!
7F6 (at 488 nm),
5D4!
7F5 (at 545 nm),
5D4!
7F4 (at 586 nm), and
5D4!
7F3 (at 623 nm). A relatively intense emission
background, due to the apatite matrix, was observed
for the Tb-doped colloid, as with the Eu-doped
system. Observed in same experimental conditions,
the Tb3þ-doped colloid emits with about the same
intensity (integrated over the range 470–720 nm) as
the Eu3þ-doped system. The [Tb3þ] 5D4 decay time
was also found to be encouragingly large, close to
2.15 0.21ms. Forthcoming works will then be
devoted to analyze further the Tb-doped systems and
to compare the luminescence advantages and draw-
backs of these Eu- and Tb-doped systems once incor-
porated in cells. This will be the object of future
reports.
Drying and re-suspension aspects
Apart from the luminescent properties of such colloids
(e.g. in view of medical imaging), another major aspect
regarding the development of imaging nanoprobes (or
drug delivery nanosystems) concerns their ability to be
stored for extended periods of time without alteration
of their characteristics. Indeed, the ageing of colloidal
suspensions may lead to an aggregation of the consti-
tuting nanoparticles. It was thus interesting at this
point to investigate the possibility to store our suspen-
sions in a dry state while retaining their initial nanopar-
ticle size. This issue is not trivial since drying processes
often lead to the formation of agglomerates of initial
particles.
The storage (and sterilization) of powder specimens
can be considered as appreciably easier than for liquid
suspensions. Therefore, in this work, tests have been
undergone by drying and subsequently re-suspending
apatite-based colloids (with the objective to preserve
an acceptable particle size in view of an intracellular
activity).
Attempts based on oven- or freeze-drying of the ‘‘as
synthesized’’ colloids followed by a re-immersion in
aqueous medium were all found to be unsuccessful as
a rapid sedimentation of the system occurred within
few seconds. This effect may probably be linked to
the high surface energy of apatite nanocrystals, which
are prone to interact strongly with each other, upon
elimination of water, in view of minimizing the total
surface energy of the system.
In this context, experiments were then run by freeze-
drying the suspensions after addition of glucose in the
medium. Very interestingly, the two largest
concentrations tested were found to lead to a successful
re-dispersion of the nanoparticles, and no sedimenta-
tion of the suspension occurred during the tests. On the
contrary, glucose concentration of 3.7mg/ml only par-
tially permitted to re-suspend the colloidal particles.
These observations were further quantified by DLS
measurements, indicating in this latter case a bi-
modal size distribution with a mean hydrodynamic
diameter close to 315 nm; while the 2 largest glucose
concentrations tested led to a mean particle size of ca.
39 nm (monomodal), which is similar to the case of the
suspension obtained after purification by dialysis and
addition of HMP (mean Dh value of 40 nm). These
results can be explained by the need to create a deep-
enough (water-soluble) glucose matrix during (freeze-
)drying so as to efficiently hinder the aggregation of
the particles during water elimination. Alike the mean
size of the particles, it is worthwhile signaling that the
other physico-chemical characteristics of the nanopar-
ticles were not modified by the presence of glucose at
the 11.1 and 18.5mg/ml concentrations, which was
ascertained by FTIR and XRD analyses. Therefore,
these findings reveal the possibility to efficiently store
such apatite-based hybrid colloids in a dry state, upon
addition of a water-soluble matrix such as glucose,
while conserving their full characteristics and keeping
the possibility to re-suspend them when appropriate
(e.g. in a biological laboratory or in peri-operative
procedures).
Evaluation of cell-targeting effects by way of FA
grafting
As reminded in the introduction section, a previous
work showed that FA could be successfully grafted
on the surface of AEP-stabilized biomimetic apatite
nanoparticles, and our data indicated the existence of
a clear FA-Ca2þ interaction, without modifying the
main physico-chemical characteristics of the apatite
colloidal nanoparticles.5 These findings are of particu-
lar relevance since FA is a well-known cell-targeting
agent for cells that overexpress folate receptors (gener-
ally denoted ‘‘FR’’) on their surface membrane, which
is the case for several types of cancer cells (e.g. some
breast or ovarian cancer cells for instance).30 It is
worthwhile reminding here that these FR (displaying
a high affinity for FA or folate molecules) should not
be confounded with the reduced folate receptors (RFC)
that are usually present on the surface of normal cells
but which interact with the reduced forms of folate mol-
ecules (e.g. dihydro- or tetrahydro-folates).31
In the present contribution, it was therefore interest-
ing to go one step beyond, by analyzing whether this
FA-grafting on the surface of apatite nanoparticles
could lead to a marked targeting effect towards cells
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Figure 6. Excitation (em¼ 540 nm) and emission
(ex¼ 379 nm) spectra for Tb-doped apatite-AEP colloids
(spectra uncorrected for the spectral response of the apparatus),
and background emission level due to the calcium phosphate
matrix. AEP: 2-aminoethylphosphoric acid.
that overexpress FR, as compared to cells that do not
specifically expose FR on their surface membrane. In
this context, we chose here to work on two types of
breast cancer cells: T-47-D (which overexpress FR,
denoted by the attribute ‘‘FRþ’’)16 and ZR-75-1
breast carcinoma cells (which do not naturally overex-
press FR, denoted ‘‘FR-’’).17 This study was specifically
run on the luminescent (Eu-doped) colloids as they rep-
resent the final types of systems to be used in the ima-
ging application envisioned here.
In vitro experiments were then initiated by contact-
ing (for 24 h) each type of cells with the colloidal nano-
particles, enriched or not with FA. The initial cell
seeding was realized with 600,000 cells, and the cell
counts after 24 h of tests were all in the range
600,000–880,000, which indicates in particular that no
significant cell death was detected. Additionally, no
direct correlation between the cell count and the tests
conditions (cell types, presence or absence of nanopar-
ticles, presence or absence of FA in the formulation of
the colloids) was evidenced.
The interaction between the cells and the colloidal
nanoparticles was then followed by measuring the
intracellular Ca2þ and Eu3þ contents via coupled
plasma atomic emission spectroscopy (ICP-AES),
after cell treatment as explained in the experimental
section. This type of ICP-based protocols has already
been exploited in the literature18 for enabling the
determination of intracellular nanoparticle uptakes.
Figure 7 reports the data obtained, both in terms of
measured Ca and Eu intracellular contents (left
Y-axis) and in terms of the corresponding nanoparti-
cle uptake (right axis, expressed in mmol of apatite).
This nanoparticle uptake was quantified directly from
the measured intracellular Ca and Eu contents found
by ICP, based on the preliminary knowledge of the Ca
and Eu contents found in the colloidal nanoparticles
themselves.
The control experiments, carried out in the absence
of nanoparticles (nor europium) in the medium, show a
rather similar and low initial calcium content (<5 mg
per million cells) for both cell types as well as the
absence of intracellular europium ions, as expected.
For cells contacted with nanoparticles without functio-
nalization by FA (NP), the analysis of intracellular Ca
and Eu values shows, in the conditions of the tests, that
both ZR-75-1 and T-47-D cells were able to internalize
some nanoparticles, in similar amounts independently
of the presence of FR receptors on the cells. However,
this amount remains limited to ca. 20 mmol of colloidal
nanoparticles per million cells (Figure 7). On the con-
trary, FA-grafted nanoparticles showed a greater ten-
dency to internalize the colloidal apatite-based
nanoparticles, for both cell types, but with in a much
more pronounced manner for the FR-positive T-47-D
cells, where the NP uptake is 3 - to 4-fold greater than
in the absence of FA functionalization. Also, the cellu-
lar uptake remains 1.5 to 2 times greater for T-47-D
cells (reaching up to 86.2mmol of colloidal nanoparti-
cles per million cells) as compared to ZR-75-1 cells
which do not overexpress FRs.
These findings point out the more selective uptake of
FA-functionalized apatite-based nanoparticles by the
FRþ-cell type (here represented by T-47-D cells), thus
evidencing some targeting abilities for such colloidal
engineered nanoparticles. This conclusion opens then
even wider perspectives aiming at substituting FA by
other cell-targeting agents so as to increase further the
targeting selectivity.
Another remarkable conclusion of these cellular
uptake data is related to the confirmation that the
methylpterin-like part of the FA molecules, which is
known to play the determining role in the recognition
by cells’ FR receptors, remained effectively biologically
active. The cellular uptake witnessed here is most likely
FA-mediated endocytosis, as is generally considered for
24h contact time - for 1 million cells
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Figure 7. Cellular uptake of nanoparticles without folic acid functionalization (NP) and with folic acid grafting (NP-FA), for ZR-75-1
(FR-) and T-47-D (FRþ) breast carcinoma cells. Data are expressed in Ca and Eu intracellular contents after contact time of 24 h.
FA-functionalized nanosystems, where the internaliza-
tion process starts right after recognition of FA by the
FR receptors.32
Conclusions
This work brought out some additional details on fun-
damental and practical aspects concerning AEP-stabi-
lized biomimetic apatite colloidal doped with
lanthanide ions (Eu3þ, Tb3þ). We have in particular
unveiled the existence of a partial non-radiative de-exci-
tation process, involving O-H oscillators present at the
vicinity of the Eu3þ luminescent centers, and the use of
Tb3þ ions was then proposed as a possible alternative
so as to limit such luminescence quenching effects.
The use of such colloidal nanoparticles could prove
helpful for time-resolved in vitro (e.g. through flow
cytometry) or even in vivo experiments, for which
long luminescence lifetimes are especially adapted so
as to allow the extinction of biological tissues
autofluoresence.
We then inspected the possibility to store such col-
loidal suspensions in a dry state, while preserving an
ability to be re-suspended easily in aqueous medium.
Our findings indicated that this was made possible,
thanks to the addition of glucose in the formulation
prior to freeze-drying, so as to lead to a water-soluble
glucose matrix surrounding the nanoparticles, thus hin-
dering their aggregation. These results should prove
helpful for the storage of such individualized nanopar-
ticles over extended periods of time, while allowing the
system to be re-suspended at the moment of use (e.g.
for medical imaging purposes).
Finally, FA surface functionalization on the col-
loidal nanoparticles made it possible to target FRþ
cancer cells (tested here on T-47-D breast carcinoma
cells) to a significantly greater level than FR- cells
(tested here on ZR-75-1 cells). These encouraging
results then open exciting perspectives, not only exploit-
ing FA targeting but also enlarging it to other targeting
agents susceptible to interact with the surface of bio-
mimetic apatite-based nanoparticles.
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